top of page
Akthelia Pharma at the International Bio Convention #BIO2025
Akthelia's CEO, Egill Masson at the International BIO Convention 2025
Akthelia News Desk
Jun 16
Prof. Dr. Markus Gerhard joins Akthelia's Scientific Advisory Board
Technical University Munich’s Prof. Dr. Markus Gerhard Joins Akthelia's Scientific Advisory Board.
Akthelia News Desk
Mar 4
New review paper published by Akthelia collaborators in Blood Reviews
Akthelia's CSO and collaborators have published a review paper on modulating innate immunity in the context of hematologic malignancies.
Akthelia News Desk
Mar 1
Akthelia Pharmaceuticals featured in Icelandic newspaper Viðskiptablaðið
Akthelia Pharmaceuticals is featured in today's edition of the leading Icelandic business newspaper Viðskiptablaðið.
Akthelia News Desk
Nov 13, 2024
Akthelia Pharmaceuticals Awarded RANNIS Grant to Accelerate Development of Gastrimod® (AKT-011) for Chemotherapy-Induced FN
Akthelia Pharmaceuticals is pleased to announce it has been awarded a two-year $350,000 research grant by RANNIS
Akthelia News Desk
Oct 17, 2024
bottom of page